Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Arthritis - One-year Phase III study shows Ilaris® offers rapid and sustained remission in patients with CAPS, a lifelong severe auto-inflammatory disease
Eye Disease - ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
Clinical Trial Research - Data from J.E. Mizoe and colleagues advance knowledge in clinical trial research
Clinical Trials - Research data from Texas A&M University update understanding of clinical trials
Colon Cancer - New colon cancer study findings have been reported from University of North Carolina
Crohn Disease - Studies from C.P. Rossi and colleagues provide new data on Crohn disease
Hepatitis C Virus - Report summarizes hepatitis C virus study findings from A. Feldstein and co-researchers
Lung Cancer - Research reports on lung cancer from Okayama University provide new insights
Lung Cancer - Study data from K. Kelly and co-authors update knowledge of lung cancer
Myeloma - Research on myeloma published by scientists at University Hospital
Non-Hodgkin Lymphoma - Research on non-hodgkin lymphoma detailed by scientists at University of Ulsan, Medical Department
Non-Small Cell Lung Cancer - Studies from K. Mori et al in the area of non-small cell lung cancer described
Pharmacokinetics - Scientists at University of Newcastle publish research in pharmacokinetics
Prostate Cancer - Research on prostate cancer discussed by scientists at University of Wisconsin
Rectal Cancer - Research findings from University of Federico II update understanding of rectal cancer
Small Cell Lung Cancer - Research from A. Morabito et al broadens understanding of small cell lung cancer
Adenocarcinoma Therapy - Investigators at Royal Marsden Hospital, Department of Medicine release new data on adenocarcinoma therapy
Carcinoma Clinical Trial - Study findings from Chiba University provide new insights into carcinoma clinical trial
Colon Cancer Therapy - New colon cancer therapy research reported from E. Vasile and co-authors
Experimental Pain Therapy - Reports on experimental pain therapy findings from GlaxoSmithKline provide new insights
Affymax, Inc. - Affymax Announces Another Data Monitoring Committee Review of Phase 3 Hematide Program
Alzheimer Disease - Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease
Amalyte Pharmaceuticals LLC - Amalyte and Meiji Enter Into a License, Development and Commercialization Agreement on AM3301 and a Novel Class of Anti-Inflammatory Compounds
Ankylosing Spondylitis - Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
Avexa Limited - Positive Outcome Reached at 16 Weeks for Avexa’s ATC Phase III Trial
Biopharmaceuticals - DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
Bone Research - Merrion Pharmaceuticals Announces Positive Phase Iib Study for Orazol Tablet Form of Zoledronate Iv Infusion At Asco Annual Meeting
Breast Cancer - Phase Ii Trials Investigating Oral Parp Inhibitor, Olaparib, In Brca-deficient Advanced Breast and Ovarian Cancer Presented During Asco 2009
Bristol-Myers Squibb and AstraZeneca - Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Bristol-Myers Squibb and AstraZeneca - Interim Analysis of Long-Term Data with ONGLYZA™ saxagliptin When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions
Diabetes - AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
Diabetes - Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions
Diabetes - FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
Diabetes - InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting
Diabetes - Reata Presents Promising Data on Bardoxolone at American Diabetes Association Annual Scientific Meeting
Drug Resistance - PolyMedix Initiates Dosing in Second Phase I Clinical Study of Novel Systemic Antibiotic Compound PMX-30063 Phase IB Clinical Study Follows the Successful Completion of the Phase IA Clinical Study
Drug Resistance - Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
Dyax Corp. - Dyax Presents Integrated Analysis of Phase 3 Data for DX-88 for Hereditary Angioedema
Dynavax Technologies Corporation - Dynavax Presents Additional Phase 3 Data for HEPLISAVTM Hepatitis B Vaccine at DDW Medical Conference
GTx, Inc. - GTx Announces Ostarine™ MK-2866 Clinical Trial Data to be Presented at ENDO 2009
Halozyme Therapeutics, Inc. - Halozyme’s Phase 2 Insulin-PH20 Study Demonstrates Faster Insulin Absorption and Superior Glucose Control in Type 1 Diabetic Patients
Heart Failure - New Study Results Presented at the American Diabetes Associations Scientific Sessions Showed ACTOplus met® (pioglitazone HCl and metformin HCl) to be Effective Initial Therapy for Patients with Type 2 Diabetes
Hodgkin Disease - Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Hormones - AEterna Zentaris Acquires All Assets from Ardana for Growth Hormone Secretagogue Compound, AEZS-130
Hypertension - Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
Incyte Corporation - Results Presented at the ADA 69th Scientific Sessions Demonstrate that INCB13739, Incyte’s Oral 11beta-HSD1 Inhibitor, Significantly Improves Glycemic Control, Insulin Sensitivity and Total Cholesterol in Patients w
Kamada - Kamada Reports Positive Proof-of-Concept Data for Inhaled Alpha-1 Antitrypsin in Bronchiectasis
Kemin Industries Inc. - Kemin Acquires Amalyte Pharmaceuticals in Bid to Expand Pharma Business
Kidney Disease - Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
Lung Cancer - ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer
Memgen - Memgen Reports Positive Results for ISF35 in High-Risk Chronic Lymphocytic Leukemia
Myeloma - Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association
Neuropathy - Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Non-Hodgkin Lymphoma - Single Dose Palonosetron Prevents Emesis Induced By Chemotherapy In Non-Hodgkin's Lymphoma Patients
NPS Pharmaceuticals, Inc. - New Findings Demonstrate Potential Benefits of GATTEX™ teduglutide in Phase 3 Study of Patients with Short Bowel Syndrome
Pharmacology - MDS Pharma Services Expands Drug Discovery Capability in Asia
Photon Energy Services - Photon Energy Services Breaks Ground on Diocese of San Jose Solar Initiative
Pneumococcal Disease - New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
Renal Disease - Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
Santarus, Inc. - Santarus Announces Schering-Plough Response Submission to FDA for OTC ZEGERID
Seattle Genetics, Inc. - Seattle Genetics Presents Final Lintuzumab Phase I Clinical Data
Seattle Genetics, Inc. - Seattle Genetics Reports Data from SGN-35 Every Three Week Dosing Phase I Trial in Lymphoma
StemCells, Inc. - StemCells, Inc. Announces Positive Phase I Batten Trial Results
Talecris Biotherapeutics, Inc. - Talecris Biotherapeutics Receives Orphan Drug Designation for Plasmin Human to Treat Acute Peripheral Arterial Occlusion
Type 2 Diabetes - Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
Type 2 Diabetes - Boehringer Ingelheim Unveils Diabetes Pipeline
Type 2 Diabetes - Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions
Type 2 Diabetes - Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients
Type 2 Diabetes - Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
University City Science Center - Royal Society of Chemistry and GADORE Center USA Make a Soft Landing at Science Center; the Center for Patient Interactive Research Launches at Science Center
